What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Myocardial infarction
- Cardiology
The scientist’s investigation covers issues in Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Clopidogrel.
His study explores the link between Internal medicine and topics such as Diabetes mellitus that cross with problems in Coronary stent.
His research brings together the fields of Randomized controlled trial and Cardiology.
The study incorporates disciplines such as Surgery and Angioplasty in addition to Myocardial infarction.
Jean-Philippe Collet has researched Percutaneous coronary intervention in several fields, including Fibrinolysis, Relative risk and Area under the curve.
His Clopidogrel study combines topics in areas such as Platelet and Anesthesia, Loading dose.
His most cited work include:
- 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC) (5768 citations)
- 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). (3314 citations)
- ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment eleva... (2231 citations)
What are the main themes of his work throughout his whole career to date?
Jean-Philippe Collet spends much of his time researching Internal medicine, Cardiology, Myocardial infarction, Clopidogrel and Percutaneous coronary intervention.
His work in the fields of Conventional PCI, Acute coronary syndrome and Coronary artery disease overlaps with other areas such as In patient.
His study in Cardiology focuses on Unstable angina, ST segment, Angioplasty, Ticagrelor and Revascularization.
His Myocardial infarction study integrates concerns from other disciplines, such as Platelet aggregation inhibitor and Odds ratio.
His work deals with themes such as Platelet and Pharmacology, which intersect with Clopidogrel.
His work in Percutaneous coronary intervention addresses issues such as Low molecular weight heparin, which are connected to fields such as Anticoagulant.
He most often published in these fields:
- Internal medicine (63.40%)
- Cardiology (53.92%)
- Myocardial infarction (25.16%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (63.40%)
- Cardiology (53.92%)
- Myocardial infarction (25.16%)
In recent papers he was focusing on the following fields of study:
Jean-Philippe Collet focuses on Internal medicine, Cardiology, Myocardial infarction, MEDLINE and Coronary artery disease.
His study in the fields of Conventional PCI, ST segment, Percutaneous coronary intervention and Revascularization under the domain of Internal medicine overlaps with other disciplines such as In patient.
Jean-Philippe Collet combines subjects such as Aspirin and Cardiothoracic surgery with his study of Cardiology.
His MEDLINE research includes elements of Treatment outcome, Peripheral Arterial Diseases and Tricuspid valve.
His Coronary artery disease research is multidisciplinary, incorporating elements of Ostium, Asymptomatic, Stenosis and Cohort.
His research integrates issues of Stroke, Thrombosis and Atrial fibrillation in his study of Clopidogrel.
Between 2017 and 2021, his most popular works were:
- 2018 ESC/EACTS Guidelines on myocardial revascularization. (2020 citations)
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). (1195 citations)
- 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS) : Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries (887 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Myocardial infarction
- Surgery
His scientific interests lie mostly in Internal medicine, Cardiology, MEDLINE, Myocardial infarction and Myocardial revascularization.
The Heart failure, ST segment and Vascular surgery research Jean-Philippe Collet does as part of his general Internal medicine study is frequently linked to other disciplines of science, such as Task force and In patient, therefore creating a link between diverse domains of science.
His ST segment research includes themes of Acute coronary syndrome, Angioplasty and Unstable angina.
His Cardiology study deals with Cardiothoracic surgery intersecting with Stent.
Many of his studies on Myocardial infarction involve topics that are commonly interrelated, such as Coronary artery disease.
His Myocardial revascularization research is multidisciplinary, incorporating perspectives in Heart team and Revascularization.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
